CAPITAL INTERNATIONAL SARL
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1065349
Los Angeles, CA
Position in ALNY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$17,651,583
-$29,808,739 QoQ
Shares Held
53,349
-55.3% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPITAL INTERNATIONAL SARL holds $242,767,746 across 8 Biotechnology names. ALNY ranks #5 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
208,882 | $93,274,168 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
173,879 | $51,636,846 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,048,202 | $50,282,249 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
24,602 | $19,008,489 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
53,349 | $17,651,583 | |
| 6 | ASND |
Ascendis Pharma A/S
|
24,749 | $5,660,838 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
102,278 | $4,865,364 | |
| 8 | CYTK |
Cytokinetics Inc
|
5,890 | $388,209 |
All Filings in ALNY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,651,583 | 53,349 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $47,460,322 | 119,352 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $59,144,112 | 129,702 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $41,832,781 | 128,286 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $32,715,623 | 121,160 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $27,094,064 | 115,142 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $37,149,127 | 135,073 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $26,685,045 | 109,815 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $10,926,140 | 73,109 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $16,721,003 | 87,357 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $15,393,886 | 86,922 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $16,030,746 | 84,399 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $15,442,668 | 77,090 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $15,893,081 | 66,876 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,872,092 | 44,325 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,502,243 | 30,869 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,174,206 | 13,315 | Shares | Defined | 2022-05-19 | |
| No filing history on record for this holder in this stock. | ||||||